Video Experimental Relacionado
Updated: Aug 12, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
La regulación de las vías naturales de anticoagulación
Science (New York, N.Y.)
|March 13, 1987
Resumen
El endotelio previene los coágulos sanguíneos utilizando la trombomodulina para activar la proteína C, un anticoagulante. La deficiencia de proteína C causa una trombosis grave, que vincula la inflamación y la coagulación.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Hematología Hematología.
- Fisiología Fisiología Fisiología.
Sus antecedentes:
- El endotelio vascular previene activamente la formación de coágulos sanguíneos.
- La trombomodulina, una proteína de la superficie celular, es clave en este proceso.
- La trombomodulina convierte la trombina en un activador de la proteína C.
Objetivo del estudio:
- Para explicar el mecanismo anticoagulante que involucra a la trombomodulina y la proteína C.
- Para resaltar la relevancia fisiológica de la vía de la proteína C.
- Para explorar el vínculo entre la inflamación y la coagulación.
Principales métodos:
- Investigó el papel de la trombomodulina en la activación de la proteína C.
- Estudió la función anticoagulante de la proteína C. activada.
- Se examinaron datos clínicos de lactantes con deficiencia de proteína C.
Principales resultados:
- La trombomodulina activa la proteína C, la cual inactiva los factores Va y VIIIa.
- La deficiencia de proteína C homocigótica conduce a complicaciones trombóticas graves.
- La vía de la proteína C conecta la inflamación y la coagulación.
Conclusiones:
- La vía de la proteína C es crucial para prevenir la trombosis.
- Los defectos en esta vía tienen graves consecuencias clínicas.
- Esta vía representa un vínculo significativo entre la inflamación y la coagulación.
Más Videos Relacionados
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...